Western Blotting Market Size to Exceed USD 1,373.9 Mn by 2032

The Western Blotting Market, estimated at USD 866.9 Mn in 2025, is expected to exhibit a CAGR of 6.8% and reach USD 1,373.9 Mn by 2032.

The market growth is driven by rising demand for accurate and early disease detection, supported by advances in molecular diagnostics, imaging, and point-of-care testing. Growing focus on personalized medicine, supportive healthcare policies, and ongoing R&D investments are creating new opportunities for industry players.

The key market players are focusing on the adoption of organic growth strategies, such as product launches to expand their product portfolio, which is expected to drive market growth over the forecast period. For instance, in June 2025, Thermo Fisher Scientific, Inc, a provider of medical equipment, analytical instruments, reagents and consumables, software, and services, announced the launch of Invitrogen iBright 1500 Imaging System Series for Western Blot and Gel Imaging.

Global Western Blotting Market– Impact of Coronavirus (COVID-19) Pandemic

The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China) in the last months of 2025 as "coronavirus disease 2025" or COVID-19. This virus spread quickly and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.

COVID-19 affected the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to the lockdown, several countries such as India, China, Brazil, and others faced problems with regard to the transportation of drugs from one place to another.

COVID-19 had a positive impact on the global western blotting market. For instance, in August 2025, according to National Center for Biotechnology Information (NCBI), the western blot (immunoblot) technique to be used to determine which protein antigens are recognized by sera from patients recovering from COVID-19 to better identify those components of the virus that should be part of a monovalent vaccine or a vaccine mixture, especially if a live, attenuated virus is not used.

Global Western Blotting Market: Key Developments

Increasing launch of products for more accurate western blotting is expected to aid in the growth of the global western blotting market. For instance, in November 2025, Bio-Rad Laboratories, Inc. launched EveryBlot Blocking Buffer, a western blot blocking reagent that offers a 5-minute blocking time and produces higher signal and lower background levels.

In May 2025, Precision BioLogic Incorporated, a leading developer of hemostasis diagnostic products, announced the launch of its new CRYOcheck Chromogenic Factor IX assay in Canada, the European Union, U.K., Australia, and New Zealand following market authorization by Health Canada and respective in-country regulatory authorities.

Browse 33 Market Data Tables and 25 Figures spread through 170 Pages and in-depth TOC on “Global Western Blotting Market”- Forecast to 2032, Global Western Blotting Market, by Product Type Electrophoresis Blotting Systems (Automated Dry Blotting Systems, Semi-Dry Blotting Systems, Traditional Wet Transfer Blotting Systems), Reagents & Kits (Chromogenic Reagents Kits, Chemiluminescent Reagents Kits)(Horseradish Peroxidase (HRP) Substrate, Alkaline Phosphatase (AP) Substrate), Fluorescent Reagents, Antibodies(Primary Antibody, Secondary Antibody),Buffer Kits, Transfer Membranes), by Application (Scientific Research, Medical Diagnostics, Agricultural Application, Food & Beverages, Other Applications), by End User (Diagnostic Laboratories, Research Institutions, Pharmaceutical & Biotechnology Companies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

To know the latest trends and insights prevalent in this market, click the link below:

https://www.coherentmarketinsights.com/market-insight/western-blotting-market-2711

Key Takeaways of the Global Western Blotting Market:

• The global western blotting market is expected to exhibit a CAGR of 6.8% during the forecast period due to the increasing emergence of COVID-19 as western blotting is widely used in the detection of antibodies in COVID-19 patients. For instance, in October 2025, according to the data published by World Health Organization, there have been 35,659,007 confirmed cases of COVID-19, which increases the demand for western blotting techniques for the detection of antibodies in COVID-19 patients.
• Among product type, electrophoresis blotting systems segment is estimated to hold a dominant position in the global western blotting market over the forecast period. For instance, in June 2025, a report published by National Center for Biotechnology Information (NCBI), stated that electrophoresis blotting systems are the most commonly used procedure to transfer proteins from a gel to a membrane.
• Among region, North America is expected to be the dominant region in the global western blotting market, owing to increasing product launches by key market players, to expand the product portfolio and strengthen their market presence, which is expected to drive the segment growth over the forecast period. For instance, in February 2025, Neogen Corporation, a developer of products dedicated to food and animal safety, announced that it has added a new chemiluminescent substrate as part of the trusted K-Blue product line.
• Major players operating in the global western blotting market include Thermo Fisher Scientific, Inc., GE HealthCare, F. Hoffmann-La Roche Ltd, Lumigen, Inc., Merck KGaA, Bio-Rad Laboratories, Inc., LI-COR, Inc., Bio-Techne, SBH Sciences, Advansta Inc., Azure Biosystems Inc., HiMedia Laboratories., Elabscience Biotechnology Inc., GenScript, Cell Signaling Technology, Inc., ICL, Inc., Takara Bio Inc., Leinco Technologies